跳至主要内容
临床试验/CTRI/2019/04/018349
CTRI/2019/04/018349尚未招募3 期

Efficacy and tolerability of plasma exchange in patients with alcohol related acute on chronic liver failure-a pilot study

Rekha Hans0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Age more than 18 years
  • 2.First episode of de-compensation with APASL ACLF Research Consortium (AARC)- ACLF grade I or II (AARC score <=10)
  • 3.Cause of ACLF being alcohol related liver disease
  • 4.No evidence of active infection
  • 5.Willing to give informed consent for the procedure(In patients who are incompetent to consent,consent shall be taken from the surrogate)

排除标准

  • 1.Pregnancy
  • 2.Causes of ACLF other than alcohol
  • 3.Co-existing HCC or extra-hepatic malignancy
  • 4.Microbiological or radiological evidence of active infection
  • 5.Active hemorrhage
  • 6.Extra-hepatic multi-organ failure (>=3 organ failures)
  • 7.APASL-AARC score >10
  • 8.Known allergy to Plasma, Protamine or Heparin.
  • 9.Mechanically ventilated patients
  • 10.Severe preexisting cardiopulmonary disease
  • 11.Requiring inotropic support
  • 12.Renal failure requiring dialysis
  • 13.Severe systemic illness like HIV
  • 14.Post liver transplant patients
  • 15.Death within 24 hours of presentation

研究者

发起方
Rekha Hans

相似试验